Resistant hypertension The Intern At Work #BJHM #MedEd #Medtwitter #Hypertension #FOAMed #Medstudenttwitter

Useful information to counsel advanced chronic kidney disease patients on what to expect in the future.

Be kind and polite to all. This may be the biggest life hack.

Keep the diastolic blood pressure above 60. Period. jamanetwork.com/journals/jaman…

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

On initiating ACE inhibitors or Angiotensin Receptor Blockers (RAS inhibitors) from RPA-Nephrology Int Society of Nephrology KDIGO European Society of Cardiology ASPC #Nephpearls #Cardiorenal #RPA24 #RPA2024 📌 Indications 📌 What to monitor 📌 How to manage changes in creatinine and potassium 👉

In general, if a critically ill patient in the ICU can last another 24 hours without acute dialysis, the evidence from recent multicenter prospective trials suggests holding off and checking again 24 hours later.

Hospitalists please take note.

Another blockbuster trial for GLP-1 agonists.

Hypertensive Urgency and Hypertensive Emergency Algorithm by Matthew Ho #medtwitter #foamed #usmle

Older patients with mild chronic kidney disease and frailty are more likely to die from falls than kidney disease complications, so this deserves attention.

In other words, intravenous normal saline at 125 ml/hr is over 10.5 grams of sodium per 24 hours. That's a lot of sodium.

The benefits of dietary proteins probably outweigh the downsides in older adults with mild-to-moderate chronic kidney disease who are unlikely to progress to end stage kidney disease but are at risk sarcopenia and frailty.

Dapagliflozin works better than metolazone as add-on therapy in furosemide resistant diuresis.

When older adults with eGFR less than 12 ml/min start dialysis, they live a little longer but spend less time at home. acpjournals.org/doi/10.7326/M2…

The Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) from KDIGO is out for public review ‼️ #KDIGOIgAN #Nephpearls 📌 Submit comments by Sept 30 🗓️ 👉 kdigo.org/guidelines/iga…

Many healthcare providers are unaware of the neurotoxic risk of cefepime, especially in advanced chronic kidney disease, acute kidney injury and dialysis patients.

Even frail patients with CKD appear to benefit from SGLT-2 inhibitors.

🫘💯Starting ACEi/ARB and Monitoring KDIGO Int Society of Nephrology

I can't wait to find out.